Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nano-X Imaging Ltd.NNOX · Entity 7098 | Director | July 28, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nano-X Imaging Ltd.
Report date July 28, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 40,792 |
Reported balance
After 2026-07-28 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2026-07-28 · Purchase · Acquired 33,000 · Balance 40,792 |
| Ordinary SharesSEC Table I · non-derivative | Direct | 17,544 |
Reported balance
Holding disclosure · report date 2026-07-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 17,544 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F2: The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy: I.B.L. Business Consulting Ltd, a company wholly owned by the reporting person | 794 |
Reported balance
Holding disclosure · report date 2026-07-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 794 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $64.61 · Expires 2031-02-09 | Direct | 12,505 |
Reported balance
Holding disclosure · report date 2026-07-28 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 12,505 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F3: The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $17.63 · Expires 2032-12-28 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-07-28 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 50,000 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F4: The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $11.52 · Expires 2033-12-31 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-07-28 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,000 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F5: The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027). |
Filing footnotes · ownership attribution and instrument terms
F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F2: The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.
F3: The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report.
F4: The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report.
F5: The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 29, 2026 11:35 UTC | Nano-X Imaging Ltd. NNOX · Entity 7098 | PurchaseOrdinary Shares | 33,000 | $0.90 | $29,700.00 |
DisclosureSEC source: 0001213900-26-082533 · ownership.xml · nonDerivative · entry 1 Kainan Noga · CIK 0002049063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,792 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.